Skip to main content

Baird Medical Investment Holdings Ltd (BDMD) research

Baird Medical Investment Holdings Ltd
ShareXLinkedInReddit
Sector
Healthcare
Industry
Medical Devices
Last price
$1.05
As of

Baird Medical Investment Holdings Ltd (BDMD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-03.

As of . Source: SEC EDGAR filings for BDMD. Method and limitations.

SHARE THIS CARD

Share the BDMD intelligence card

A branded snapshot of BDMD: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion BDMD intelligence card preview
Post to X
LIVE TERMINAL

See BDMD live in the terminal

Track BDMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live BDMD terminal, free

Active signals for BDMD

FREE, NO ACCOUNT

Every signal on BDMD, as it fires

You are seeing 5 of 7 signals recorded on BDMD since 2026-08-16.

The five above landed across 2 days. The other 2 were recorded on those same days. 7 of the 7 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in BDMD (2026Q2)

Manager / securityMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LPCUSIP G0705H103 · 2026Q2$64K0.00%,
RENAISSANCE TECHNOLOGIES LLCCUSIP G0705H103 · 2026Q2$64K0.00%,
CITADEL ADVISORS LLCCUSIP G0705H103 · 2026Q2$63K0.00%,
D. E. Shaw & Co., Inc.CUSIP G0705H111 · 2026Q2$6K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BDMD

BDMD against its peers

BDMD's operating margin of -113.7% ranks in the 48th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.

MetricBDMDPeer medianPercentilen
Revenue FY22.5M USD18.9M USD5623
Revenue YoY-39.2%n/an/a3
Gross margin83.8%49.1%9320
Operating margin-113.7%-55.8%4823
Net margin-121.0%-48.4%4023
Return on equity-87.0%-88.4%5221

Peers (24): SNWV, ELUT, NSPR, QTI, NSYS, PAVM, ARAY, TELA, FOFA, XTNT, PETV, RDGL, MDAI, GTHP, MYO, SRTS, COCH, MDNC, NNOX, POSC, MODD, RPID, OM, CTSO. Left out: TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BDMD: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more BDMD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to BDMDand get the insider, 13F, options, and confluence read in one view.

Open the live BDMD terminal, free